No Data
No Data
Jilin Aodong Pharmaceutical Group Co., Ltd.'s (SZSE:000623) Shares Leap 46% Yet They're Still Not Telling The Full Story
jilin aodong pharmaceutical group (000623.SZ): The holding subsidiary has obtained pharmaceutical registration certificate and traditional chinese medicine formula granule listing record certificate.
Gelonghui September 25th | Jilin Aodong (000623.SZ) announced that recently, Jilin Aodong Pharmaceutical Group Co., Ltd., a subsidiary of Jilin Aodong Pharmaceutical Group, received the "Pharmaceutical Registration Certificate" for Levofloxacin Eye Drops with specifications of 0.488% (0.4ml: 1.952mg) issued by the National Medical Products Administration. The holding subsidiary Jilin Aodong Yanji Pharmaceutical Group Co., Ltd. (referred to as "Yanji Pharmaceutical") obtained 14 "Traditional Chinese Medicine Formula Granule Listing Certificates" for its subsidiary Jilin Aodong Yanbian Pharmaceutical Co., Ltd. (referred to as "Yanbian Pharmaceutical").
Shareholders 15% Loss in Jilin Aodong Pharmaceutical Group (SZSE:000623) Partly Attributable to the Company's Decline in Earnings Over Past Three Years
Jilin Aodong Pharmaceutical Group's H1 Profit Plummets 49% as Operating Income Slides 11%
Aodong, Jilin: Summary of the 2024 Semi-Annual Report
Aodong, Jilin: Semi-Annual Report 2024
No Data
No Data